Search Grant Opportunities

Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS)

ID: RFA-DP-25-126 • Type: Posted

Description

This NOFO will provide supplemental funding to CDC Prevention Research Centers (PRCs) to conduct Special Interest Projects (SIPs). The purpose of the SIPs is to inform public health practice through high-quality applied health promotion and disease prevention public health research in real-world settings to identify, design, test, assess, evaluate, disseminate, and translate interventions (i.e., programs, practices, policies, or strategies) and tools or resources to prevent and reduce risk for the leading causes of illness, disability, and death in the United States. The seven SIPs that will be included in this NOFO are: (1) Validating survey questions on prostate cancer screening including PSA testing and shared decision-making; (2) Prostate cancer active surveillance identification using electronic health record; (3) Practice-based evidence on approaches for accurate identification and appropriate selection of individuals for lung cancer screening; (4) Lifestyle Change Implementation Research Network (LCIRN); (5) Understanding the potential of early childcare and education (ECE) centers in promoting childhood vaccines and RSV prevention products; (6) Overdose Prevention and Treatment Research Network (OPTRN) ; and (7) Scaling What Works within the National Comprehensive Cancer Control Program.
Background
The Centers for Disease Control and Prevention (CDC), specifically the National Center for Chronic Disease Prevention and Health Promotion, is issuing this Notice of Funding Opportunity (NOFO) to provide supplemental funding to CDC Health Promotion and Disease Prevention Research Centers (PRCs).

The goal of this funding is to conduct Special Interest Projects (SIPs) that inform public health practice through high-quality applied health promotion and disease prevention research in real-world settings. This initiative aims to identify, design, test, assess, evaluate, disseminate, and translate interventions that can prevent and reduce risks associated with the leading causes of illness, disability, and death in the United States.

Grant Details
The NOFO supports seven specific SIPs:
1) Validating survey questions on prostate cancer screening including PSA testing and shared decision-making;
2) Prostate cancer active surveillance identification using electronic health records;
3) Practice-based evidence on approaches for accurate identification and appropriate selection of individuals for lung cancer screening;
4) Lifestyle Change Implementation Research Network (LCIRN);
5) Understanding the potential of early childcare and education centers in promoting childhood vaccines and RSV prevention products;
6) Overdose Prevention and Treatment Research Network (OPTRN);
7) Scaling What Works within the National Comprehensive Cancer Control Program.

Recipients will engage in activities such as identifying strategies for intervention design, testing developed interventions for efficacy, conducting dissemination research, and implementing strategies to sustain interventions in public health practice.

Eligibility Requirements
Eligible applicants must be institutions approved for funding under CDC Notice of Funding Opportunity RFA-DP-24-004. Foreign organizations are not eligible to apply. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply. Each institution can submit only one application per SIP.

Period of Performance
The total period of performance is four years, from September 30, 2025, to September 29, 2029.

Grant Value
The estimated total funding available for this NOFO is $21,858,000. It is anticipated that up to 12 awards will be made under this NOFO with an award ceiling of $5,902,000 per budget period.

Place of Performance
The grant activities will be performed at various CDC Health Promotion and Disease Prevention Research Centers across the United States.

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 12/12/24 Centers for Disease Control and Prevention posted grant opportunity RFA-DP-25-126 for Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS) with funding of $21.9 million. The grant will be issued under grant program 93.135 Centers for Research and Demonstration for Health Promotion and Disease Prevention. It is expected that 12 total grants will be made.

Timing

Posted Date
Dec. 12, 2024, 12:00 a.m. EST
Closing Date
Feb. 28, 2025, 12:00 a.m. EST Past Due
Closing Date Explanation
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Last Updated
Dec. 12, 2024, 2:58 p.m. EST
Version
1
Archive Date
March 31, 2025

Eligibility

Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
Applicants must be approved for funding under CDC Notice of Funding Opportunity RFA-DP-24-004 Health Promotion and Disease Prevention Research Centers in order to apply for SIP supplemental funding under this announcement. On the SIP applicant's SF424 (R&R), the institution's legal name, EIN, and UEI (sections 8a, b and c of SF424) must match the information of the institution selected for funding under RFA-DP-24-004 as listed in the Notice of Award. Special eligibility may apply to each SIP that will be listed in the NOFO. The 20 institutions currently approved for funding under CDC RFA-DP-24-004 as CDC Prevention Research Centers (PRCs) are: CDC Grant # PRC Recipient U48 DP006809 Emory University; U48 DP006803 Georgia State University; U48 DP006785 Harvard School of Public Health; U48 DP006802 Morehouse School of Medicine; U48 DP006778 New York University School of Medicine; U48 DP006816 San Diego State University; U48 DP006799 University of Arizona; U48 DP006814 University of Arkansas for Medical Sciences; U48 DP006806 University of California, San Francisco; U48 DP006812 University of Iowa; U48 DP006808 University of Massachusetts Medical School Worcester; U48 DP006791 University of Michigan at Ann Arbor; U48 DP006787 University of Minnesota; U48 DP006807 University of North Carolina at Chapel Hill; U48 DP006801 University of Pennsylvania; U48 DP006792 University of Pittsburgh; U48 DP006779 University of Rochester; U48 DP006780 University of South Carolina at Columbia; U48 DP006789 University of Utah; and U48 DP006793 University of Wisconsin-Madison.

Award Sizing

Ceiling
$5,902,000
Floor
Not Listed
Estimated Program Funding
$21,858,000
Estimated Number of Grants
12

Contacts

Contact
Centers for Disease Control and Prevention - ERA
Contact Email
Contact Phone
(404) 498-2015

Documents

Posted documents for RFA-DP-25-126

Potential Applicants and Partners

Awardees that have recently won grants similar to RFA-DP-25-126

Incumbent or Similar Grants

Grants similar to RFA-DP-25-126

Similar Active Opportunities

Open grant opportunities similar to RFA-DP-25-126